Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
DOI
PMC
 |
|
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
Prognostic relevance of minimal residual disease in colorectal cancer.
World J. Gastroenterol. 20, 10296-10304 (2014)
Presence of occult minimal residual disease in patients with colorectal cancer (CRC) has a strong prognostic impact on survival. Minimal residual disease plays a major role in disease relapse and formation of metastases in CRC. Analysis of circulating tumor cells (CTC) in the blood is increasingly used in clinical practice for disease monitoring of CRC patients. In this review article the role of CTC, disseminated tumor cells (DTC) in the bone marrow and micrometastases and isolated tumor cells (ITC) in the lymph nodes will be discussed, including literature published until September 2013. Occult disease is a strong prognostic marker for patient survival in CRC and defined by the presence of CTC in the blood, DTC in the bone marrow and/or micrometastases and ITC in the lymph nodes. Minimal residual disease could be used in the future to identify patient groups at risk, who might benefit from individualized treatment options.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
0.000
1.328
24
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Circulating Tumor Cells ; Colorectal Cancer ; Disseminated Tumor Cells ; Isolated Tumor Cells ; Micrometastases ; Minimal Residual Disease ; Occult Disease
Language
english
Publication Year
2014
HGF-reported in Year
0
ISSN (print) / ISBN
1007-9327
e-ISSN
2219-2840
Quellenangaben
Volume: 20,
Issue: 30,
Pages: 10296-10304
Publisher
WJG Press
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
PubMed ID
25132746
Erfassungsdatum
2014-12-31